Field safety comparison of ERYSENG® PARVO/LEPTO vs two commercial vaccines

Accueil Connaissances Field safety comparison of ERYSENG® PARVO/LEPTO vs two commercial vaccines

Field safety comparison of ERYSENG® PARVO/LEPTO vs two commercial vaccines

The objective of this study was to compare the safety of ERYSENG® PARVO/LEPTO with two different commercially available vaccines under field conditions, using the increase in rectal temperature in gilts caused after the primary vaccination

À propos de cet article

Paru dans

IPVS Congress, 2016

Auteurs

Scherer, C.; Puig, A.; Camprodon, A.; Coll, M.; Cesio, M.; March, R.

Résumé

Although all the products in this study met the established safety requirements and parameters, the data presented show the optimum performance obtained with the new vaccine ERYSENG® PARVO/LEPTO, which achieved safety levels equal to or better than its competitors in terms of increase in post-vaccination temperature.

Services liés

Partager